Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in J Investig Allergol Clin Immunol Retrieve available abstracts of 21 articles: HTML format

Single Articles

October 2025
1. ESTRAVIS M, Carreiras-Quintas D, Trivino JC, Perez-Pazos J, et al
   Identification of Dual Super-Response in Patients With Asthma and CRSwNP Treated With Mepolizumab.
   J Investig Allergol Clin Immunol. 2025 Oct 24:0. doi: 10.18176/jiaci.1102.
   PubMed     Abstract available
   
   
   July 2025
2. SALDANA-PEREZ LE, Serrano Pariente J, Cisneros Serrano C, Plaza V, et al
   Dynamic Hyperinflation in Patients With Moderate-Severe Asthma: Relationship With Clinical Control and Small Airway Dysfunction.
   J Investig Allergol Clin Immunol. 2025 Jul 30:0. doi: 10.18176/jiaci.1088.
   PubMed     Abstract available
   
   
   April 2025
3. CALZADA D, Bartra J, Serrano CD, Riggioni S, et al
   Differences in Molecular Sensitization Profiles Between Spanish and Latin American Mite-Allergic Patients.
   J Investig Allergol Clin Immunol. 2025;35:114-121.
   PubMed     Abstract available
   
   
   March 2025
4. GARCIA-RIO F
   The Evolving Role of Lung Function Interpretation: Clinical Implications of the new ERS/ATS Standards in Asthma Care.
   J Investig Allergol Clin Immunol. 2025 Mar 14:0. doi: 10.18176/jiaci.1084.
   PubMed     Abstract available
   
   
   
5. BANTULA M, Garcia A, Picado C, Arismendi E, et al
   Obese Asthma Syndrome: Multiple Inflammatory Patterns and A Key Solution.
   J Investig Allergol Clin Immunol. 2025 Mar 5:0. doi: 10.18176/jiaci.1071.
   PubMed    
   
   
   January 2025
6. SOUSA-PINTO B, Savoure M, Vieira RJ, Amaral R, et al
   Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.
   J Investig Allergol Clin Immunol. 2025 Jan 23:0. doi: 10.18176/jiaci.1047.
   PubMed     Abstract available
   
   
   November 2024
7. OJANGUREN I, Quirce S, Bobolea I, Perez de Llano L, et al
   Phenotyping Asthma Exacerbations: One Step Further in the Management of Severe Asthma.
   J Investig Allergol Clin Immunol. 2024 Nov 28:0. doi: 10.18176/jiaci.1043.
   PubMed     Abstract available
   
   
   
8. MASCARO-HEREZA B, Loli-Ausejo D, Valero A, Arismendi E, et al
   Effectiveness of Biologics in Patients With Severe Asthma and Psychiatric Comorbidities.
   J Investig Allergol Clin Immunol. 2024 Nov 27:0. doi: 10.18176/jiaci.1034.
   PubMed    
   
   
   
9. RIAL MJ, Betancor D, Canas JA, Olaguibel JM, et al
   Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project.
   J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1026.
   PubMed    
   
   
   
10. MIRALLES-LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, et al
    Tezepelumab in Patients With Severe Asthma: Response at 3 Months.
    J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1041.
    PubMed    
    
    
    
11. OZDEMIR O
    Occupational Asthma and Rhinoconjunctivitis due to Soybean in a Bakery Worker.
    J Investig Allergol Clin Immunol. 2024 Nov 13:0. doi: 10.18176/jiaci.1035.
    PubMed    
    
    
    
12. LOZANO-ESPINOSA M, Rodriguez-Otero N, Antolin-Amerigo D, Gordo Vidal F, et al
    Characteristics of Asthma Patients Admitted to the Intensive Care Unit of a Tertiary University Hospital in Madrid, Spain: A 5-Year Experience.
    J Investig Allergol Clin Immunol. 2024 Nov 12:0. doi: 10.18176/jiaci.1021.
    PubMed    
    
    
    October 2024
13. POLA-BIBIAN B, Dominguez-Ortega J, Vila-Nadal G, Entrala A, et al
    Asthma Exacerbations in a Tertiary Hospital: Clinical Features, Triggers, and Risk Factors for Hospitalization.
    J Investig Allergol Clin Immunol. 2024;27:238-245.
    PubMed     Abstract available
    
    
    
14. PLAZA V, Eguiluz I, Garin N, Martinez Moragon E, et al
    EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma.
    J Investig Allergol Clin Immunol. 2024;34:336-338.
    PubMed    
    
    
    July 2024
15. VENEGAS GARRIDO C, Nair P, Davila I, Perez de Llano L, et al
    Role of Thymic Stromal Lymphopoietin in the Pathophysiology of Asthma and Clinical and Biological Effects of Blockade With Tezepelumab.
    J Investig Allergol Clin Immunol. 2024 Jul 26:0. doi: 10.18176/jiaci.1012.
    PubMed     Abstract available
    
    
    June 2024
16. BETANCOR D, Otal M, Olaguibel JM, Rodrigo-Munoz JM, et al
    Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort.
    J Investig Allergol Clin Immunol. 2024;34:192-195.
    PubMed    
    
    
    
17. ZAKZUK J, Donado K, Mondol E, Marrugo V, et al
    IgE-Mediated Sensitization to Blo t 21 and Blo t 5 Is Associated With Asthma in the Tropics: A Case-Control Study.
    J Investig Allergol Clin Immunol. 2024;34:157-166.
    PubMed     Abstract available
    
    
    May 2024
18. SOUSA-PINTO B, Fonseca JA, Bousquet J
    Contribution of MASK-air(R) as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma.
    J Investig Allergol Clin Immunol. 2024 May 14:0. doi: 10.18176/jiaci.0994.
    PubMed     Abstract available
    
    
    
19. TOMAS-PEREZ M, Trisan Alonso A, Montoro-Ferrer A, Dominguez-Ortega J, et al
    Concomitant Efficacy of Dupilumab in Treating Eosinophilic Esophagitis and Type 2 Asthma.
    J Investig Allergol Clin Immunol. 2024 May 9:0. doi: 10.18176/jiaci.1011.
    PubMed    
    
    
    April 2024
20. DE LAS VECILLAS L, Quirce S
    The Multiple Trajectories of the Allergic March.
    J Investig Allergol Clin Immunol. 2024;34:75-84.
    PubMed     Abstract available
    
    
    February 2024
21. SOUSA-PINTO B, Palamarchuk Y, Leemann L, Jankin S, et al
    From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe).
    J Investig Allergol Clin Immunol. 2024;34:12-19.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.